A cost-effectiveness analysis of treatment strategies for acute uncomplicated pyelonephritis in women

Academic Emergency Medicine

Volumn 10, Issue 4, 2003, Pages 309-314

  Yen, Zui Shen ^a   Davis, Mark A ^b   Chen, Shyr Chyr ^a,c   Chen, Wen Jone ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cost benefit analysis; Costs; Norfloxacin; Pyelonephritis; Trimethoprim sulfamethoxazole

Indexed keywords

COTRIMOXAZOLE; NORFLOXACIN;

ACUTE PYELONEPHRITIS; ADULT; AGED; ANAPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; COST EFFECTIVENESS ANALYSIS; DECISION THEORY; DRUG COST; DRUG EFFICACY; EPIGASTRIC PAIN; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; RASH; TREATMENT OUTCOME; VAGINITIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS; ANTI-INFECTIVE AGENTS, URINARY; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FEMALE; HEALTH CARE COSTS; HUMANS; MIDDLE AGED; NORFLOXACIN; PYELONEPHRITIS; QUALITY OF LIFE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0037387760     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/aemj.10.4.309     Document Type: Article

References (25)

1. Stamm WE, Hooton TM, Johnson JR, et al. Urinary tract infections: from pathogenesis to treatment. J Infect Dis. 1989; 159:400-6.
2. Safrin S, Siegel D, Black D. Pyelonephritis in adult women: inpatient versus outpatient therapy. Am J Med. 1988; 85:793-8.
3. Stamm WE, Hooton TM. Management of urinary tract infection in adults. N Engl J Med. 1993; 329:1328-34.
4. Ronald AR, Nicolle LE, Harding KM. Standards of therapy for urinary tract infections in adults. Infection. 1992; 20(suppl 2): S164-S170.
5. Israel MR, Lowenstein SR, Marx J, Koziol-McLain J, Svoboda L, Ranniger S. Management of acute pyelonephritis in an emergency department observation unit. Ann Emerg Med. 1991; 20:253-7.
6. Ward G, Jorden RC, Severance HW. Treatment of pyelonephritis in an observation unit. Ann Emerg Med. 1991; 20:258-61.
7. Hooton TM, Stamm WE. Management of acute uncomplicated urinary tract infection in adults. Med Clin North Am. 1991; 75:339-57.
8. Sabbaj J, Hoagland VL, Shih WJ. Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections. Antimicrob Agents Chemother. 1985; 27:297-301.
9. Guerra JG, Falconi E, Palomino JC, Benavente L, Mayolo EA. Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections. Eur J Clin Microbiol. 1983; 2:260-5.
10. Hasse DA, Harding GKM, Thomson MJ, Kennedy JK, Urias BA, Ronald AR. Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora. Antimicrob Agents Chemother. 1984; 26:481-4.
11. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am. 1997; 11:551-81.
12. Johnson JR, Stamm WE. Diagnosis and treatment of acute urinary tract infections. Infect Dis Clin North Am. 1987; 1:773-91.
13. Talan DA, Stamm WE, Hooton TM, et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA. 2000; 283:1583-90.
14. Stamm WE, McKevitt M, Counts GW. Acute renal infection in women: treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks: a randomized trial. Ann Intern Med. 1987; 106:341-5.
15. The Urinary Tract Infections Study Group. Coordinated multicenter study of norfloxacin versus trimethoprim-sulfamethoxazole treatment of symptomatic urinary tract infection. J Infect Dis. 1987; 155:170-7.
16. Mouton Y, Ajana F, Chidiac C, Capron MH, Home P, Masquelier AM. A multicenter study of lomefloxacin and trimethoprim/ sulfamethoxazole in the treatment of uncomplicated acute pyelonephritis. Am J Med. 1992; 92(suppl 4A):87S-90S.
17. Sandberg T, Englund G, Lincoln K, Nilsson LG. Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis. Eur J Clin Microbiol Infect Dis. 1990; 9:317-23.
18. Hyslop DL, Bischoff W. Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis. Am J Med. 1992; 92(suppl 6A):86S-94S.
19. Cronberg SBanke S, Bergman B, et al. Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime. Scand J Infect Dis. 2001; 33:339-43.
20. Watt B, Chait I, Kelsey MC, et al. Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections - a multi-centre trial. J Antimicrob Chemother. 1984; 13(suppl B):89-94.
21. Vogel R, Deaney NB, Round EM, VandenBurg MJ, Currie WJ. Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid. A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections. J Antimicrob Chemother. 1984; 13(suppl B):113-20.
22. Deaney NB, Vogel R, Vandenburg MJ, Currie WJ. Norfloxacin in acute urinary tract infections. Practitioner. 1984; 228(1387):111-7.
23. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ. 1986; 5:1-30.
24. Berg PA, Daniel PT. Co-trimoxazole-induced hepatic injury - an analysis of cases with hypersensitivity-like reactions. Infection. 1987; 15(suppl 5):S259-S264.
25. Ilario MJ, Ruiz JE, Axiotis CA. Acute fulminant hepatic failure in a woman treated with phenytoin and trimethoprimsulfamethoxazole. Arch Pathol Lab Med. 2000; 124:1800-3.